3.41
price down icon1.16%   -0.04
after-market 시간 외 거래: 3.41
loading
전일 마감가:
$3.45
열려 있는:
$3.46
하루 거래량:
530.32K
Relative Volume:
0.55
시가총액:
$653.12M
수익:
$12.99M
순이익/손실:
$-74.39M
주가수익비율:
-7.75
EPS:
-0.44
순현금흐름:
$-78.92M
1주 성능:
+0.00%
1개월 성능:
-5.01%
6개월 성능:
-8.82%
1년 성능:
+2.10%
1일 변동 폭
Value
$3.36
$3.48
1주일 범위
Value
$3.31
$3.53
52주 변동 폭
Value
$2.705
$4.725

Arbutus Biopharma Corp Stock (ABUS) Company Profile

Name
명칭
Arbutus Biopharma Corp
Name
전화
604-419-3200
Name
주소
701 VETERANS CIRCLE, WARMINSTER, PA
Name
직원
44
Name
트위터
@arbutusbio
Name
다음 수익 날짜
2025-03-26
Name
최신 SEC 제출 서류
Name
ABUS's Discussions on Twitter

ABUS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ABUS
Arbutus Biopharma Corp
3.41 653.11M 12.99M -74.39M -78.92M -0.44
Biotechnology icon
ONC
Beone Medicines Ltd Adr
258.27 26.01B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.85 114.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.3499 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
83.98 6.29B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
484.93 63.90B 14.09B 4.50B 2.96B 39.28

Arbutus Biopharma Corp Stock (ABUS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-02-02 업그레이드 Jefferies Hold → Buy
2021-02-25 개시 Jefferies Hold
2020-12-17 개시 H.C. Wainwright Buy
2020-07-27 재개 JMP Securities Mkt Outperform
2020-07-24 다운그레이드 Robert W. Baird Outperform → Neutral
2020-05-19 업그레이드 Wedbush Neutral → Outperform
2020-03-06 업그레이드 Chardan Capital Markets Neutral → Buy
2020-02-20 개시 Robert W. Baird Outperform
2020-02-05 업그레이드 JMP Securities Mkt Perform → Mkt Outperform
2019-10-07 재확인 B. Riley FBR Buy
2019-10-04 다운그레이드 Chardan Capital Markets Buy → Neutral
2018-10-16 업그레이드 B. Riley FBR Neutral → Buy
2018-10-15 업그레이드 Wedbush Underperform → Neutral
2018-10-12 재확인 Chardan Capital Markets Buy
2018-07-06 다운그레이드 B. Riley FBR, Inc. Buy → Neutral
2018-03-19 재개 Chardan Capital Markets Buy
2018-03-19 다운그레이드 Wedbush Outperform → Neutral
2018-01-05 개시 B. Riley FBR, Inc. Buy
2017-04-04 업그레이드 Chardan Capital Markets Neutral → Buy
2017-02-01 재확인 Wedbush Outperform
2016-12-13 다운그레이드 Chardan Capital Markets Buy → Neutral
2016-11-30 업그레이드 Chardan Capital Markets Neutral → Buy
모두보기

Arbutus Biopharma Corp 주식(ABUS)의 최신 뉴스

pulisher
May 29, 2025

Deutsche Bank AG Buys 75,212 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

May 29, 2025
pulisher
May 22, 2025

Northern Trust Corp Has $4.35 Million Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

May 22, 2025
pulisher
May 18, 2025

Arbutus Biopharma Reports Q1 2025 Results, Clinical Developments, and Legal Progress - MyChesCo

May 18, 2025
pulisher
May 18, 2025

Mercer Global Advisors Inc. ADV Makes New Investment in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

May 18, 2025
pulisher
May 18, 2025

Arbutus Biopharma Co. (NASDAQ:ABUS) Stake Boosted by Price T Rowe Associates Inc. MD - Defense World

May 18, 2025
pulisher
May 15, 2025

Arbutus: Q1 Earnings Snapshot - CT Insider

May 15, 2025
pulisher
May 14, 2025

Arbutus Biopharma Corp Reports Q1 2025 Earnings: Revenue at $1.8 Million, EPS Misses Estimate with $0.13 Loss - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Arbutus Biopharma earnings missed by $0.03, revenue fell short of estimates - Investing.com Canada

May 14, 2025
pulisher
May 14, 2025

Arbutus Biopharma (ABUS) Reports Mixed Q1 Results - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Arbutus Biopharma (ABUS) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 14, 2025
pulisher
May 14, 2025

Arbutus (ABUS) Reports Lower Q1 Revenue Amid Promising Treatment Progress | ABUS Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Arbutus Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 14, 2025
pulisher
May 13, 2025

Is Editas Medicine (EDIT) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

May 13, 2025
pulisher
May 10, 2025

Arbutus Biopharma Showcases Promising Results for Hepatitis B Therapies at EASL Congress 2025 - MyChesCo

May 10, 2025
pulisher
May 08, 2025

Wells Fargo & Company MN Acquires 21,768 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

May 08, 2025
pulisher
May 07, 2025

Arbutus Biopharma (ABUS) Showcases Promising Data on Imdusiran and AB-101 | ABUS Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Arbutus Presents Clinical Trial Data from its Two HBV - GlobeNewswire

May 07, 2025
pulisher
May 06, 2025

Arbutus Biopharma Co. (NASDAQ:ABUS) Shares Purchased by Barclays PLC - Defense World

May 06, 2025
pulisher
May 05, 2025

Invesco Ltd. Grows Position in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

May 05, 2025
pulisher
May 02, 2025

Arbutus Biopharma Corp (ABUS) is a good investment, but the stock may be overvalued - uspostnews.com

May 02, 2025
pulisher
May 01, 2025

Arbutus Biopharma Corp (ABUS) With A Potential Upside Of More Than -139.44% - Stocksregister

May 01, 2025
pulisher
May 01, 2025

Arbutus Biopharma Corp (ABUS) looking to reclaim success with recent performance - Sete News

May 01, 2025
pulisher
May 01, 2025

Legal & General Group Plc Has $388,000 Stock Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

May 01, 2025
pulisher
Apr 30, 2025

Arbutus Biopharma Corp [ABUS] Insider Activity: An Update for Investors - knoxdaily.com

Apr 30, 2025
pulisher
Apr 28, 2025

Arbutus Biopharma Corp expected to post a loss of 10 cents a shareEarnings Preview - TradingView

Apr 28, 2025
pulisher
Apr 26, 2025

Stock Market Recap: Arbutus Biopharma Corp (ABUS) Concludes at 3.12, a -1.58 Surge/Decline - DWinneX

Apr 26, 2025
pulisher
Apr 25, 2025

Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Apr 25, 2025
pulisher
Apr 24, 2025

Will Arbutus Biopharma (ABUS) Report Negative Q1 Earnings? What You Should Know - Yahoo Finance

Apr 24, 2025
pulisher
Apr 24, 2025

Arbutus Biopharma Showcases Promising Hepatitis B Research at EASL Congress - MyChesCo

Apr 24, 2025
pulisher
Apr 23, 2025

Arbutus Biopharma Corp (ABUS)’s stock price in review: A technical analysis - uspostnews.com

Apr 23, 2025
pulisher
Apr 23, 2025

Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025 - GlobeNewswire

Apr 23, 2025
pulisher
Apr 21, 2025

Alliancebernstein L.P. Has $393,000 Stock Position in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Apr 21, 2025
pulisher
Apr 19, 2025

Franklin Resources Inc. Takes $301,000 Position in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Apr 19, 2025
pulisher
Apr 15, 2025

Arbutus Biopharma Co. (NASDAQ:ABUS) Shares Purchased by Vanguard Group Inc. - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

Raymond James Financial Inc. Takes $34,000 Position in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Apr 14, 2025
pulisher
Apr 13, 2025

Wellington Management Group LLP Buys 16,484 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

Corebridge Financial Inc. Has $238,000 Stock Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

KLP Kapitalforvaltning AS Invests $84,000 in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Apr 11, 2025
pulisher
Apr 03, 2025

Teacher Retirement System of Texas Raises Stock Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

Warminster-Based Arbutus Biopharma Lays Off Over Half of Workforce, Exits Its Headquarters - BUCKSCO.Today

Apr 02, 2025
pulisher
Apr 01, 2025

Moderna (NasdaqGS:MRNA) Faces Legal Spotlight Affecting Investor Sentiment with -8% Dip Over Last Month - Yahoo Finance

Apr 01, 2025
pulisher
Apr 01, 2025

Arbutus Biopharma Corp (NASDAQ: ABUS) – An Analysis Is What You Need - stocksregister.com

Apr 01, 2025
pulisher
Mar 31, 2025

Layoff Tracker: Arbutus Cuts 57% of Workforce - BioSpace

Mar 31, 2025
pulisher
Mar 31, 2025

Is Arbutus Biopharma (ABUS) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Mar 31, 2025
pulisher
Mar 30, 2025

Arbutus Biopharma Reports 2024 Financial Results and Strategic Updates - MSN

Mar 30, 2025
pulisher
Mar 30, 2025

Xponance Inc. Takes $34,000 Position in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Mar 30, 2025
pulisher
Mar 30, 2025

Chardan Capital Reiterates “Buy” Rating for Arbutus Biopharma (NASDAQ:ABUS) - Defense World

Mar 30, 2025
pulisher
Mar 29, 2025

Arbutus Biopharma (NASDAQ:ABUS) Trading 4.1% Higher Following Strong Earnings - Defense World

Mar 29, 2025

Arbutus Biopharma Corp (ABUS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$1.16
price up icon 0.00%
$573.50
price down icon 0.54%
$36.08
price up icon 15.90%
$305.31
price up icon 0.51%
$4.75
price up icon 3.70%
$484.93
price down icon 0.60%
자본화:     |  볼륨(24시간):